The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital

Nephrology Dialysis Transplantation

Volumn 20, Issue 10, 2005, Pages 2202-2206

  Lim, Christopher Thiam Seong ^a   Wong, Kok Seng ^a   Foo, Marjore Wai Yin ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Albumins; CAPD; Exit site infection; Mupirocin; Peritonitis; Staphylococcus aureus

Indexed keywords

CEFAZOLIN; PSEUDOMONIC ACID; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COMORBIDITY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SINGAPORE; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, TOPICAL; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; HOSPITALS, GENERAL; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SINGAPORE; STAPHYLOCOCCAL INFECTIONS;

EID: 27144455176     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi010     Document Type: Article

References (20)

1. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17: 360-364
2. Piraino B. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 1990; 16: 89-95
3. Thodis E, Bhaskaran S, Pasadakis, P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the Catheter exit site. Perit Dial Int 1998; 18: 261-270
4. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes RA. Randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695-700
5. Casey M, Taylor J, Clinard P et al. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 566-568
6. Hudson IR. The efficacy of intranasal mupirocin in the prevention of Staphylococcal infections: A review of recent experience. J Hosp Infect 1994; 27: 81-98
7. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 1985; 27: 495-498
8. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in Gram-negative infections in peritonea] dialysis patients. Perit Dial Int 2003; 23: 456-459
9. Szeto CC, Chow KM, Leung CB et al. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases. Kidney Int 2001; 59: 2309-2315
10. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261-270
11. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-2408
12. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: A review. Perit Dial Int 1991; 11: 333-340
13. Casey M, Taylor J, Clinard P et al. Application of mupirocin crearn at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 566-568
14. Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial 2000; 16: 257-261
15. Vas SI, Conly J, Bargman JM, Oreopoulos DG. Resistance to mupirocin: No indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients. Perit Dial Int 1999; 19: 313-314
16. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337-341
17. Annigeri R, Conly J, Vas S et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554-559
18. Bernardini J, Bender F, Florio T el al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-545
19. Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritonea] dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41: 664-669
20. Sharma AP, Gupta A, Sharma RK, Agarwal DK, Sural S, Wardhe. DJ. Does serum albumin at start of continuous ambulatory peritoneal dialysis (CAPD) or its drop during CAPD determine patient outcome? Adv Perit Dial 2000; 16: 119-122